Tim Anderson
Tim Anderson
Timothy Devon Andersonis an American professional baseball shortstop for the Chicago White Sox of Major League Baseball. Anderson played college baseball at East Central Community College, and was selected in the first round of the 2013 MLB draft by the White Sox. He made his MLB debut on June 10, 2016...
ProfessionBaseball Player
Date of Birth23 June 1993
burnt fortune good great hole knocking last putt
I had the good fortune of knocking my 2-3-foot putt in on the last hole and Doug's just burnt the edge. He was a great competitor.
addition goes homes single taken technician
In addition to that, he does not go into customers' homes alone. I have another technician that goes with him on every single job. We've taken precautions.
ball leaves miss rebound shot tough vulnerable win
It's tough to win doing that. They miss the shot but when you don't rebound the ball it leaves you vulnerable for another shot and you see what happens.
great pro
It's a great following. It's our pro sport.
biggest deals hurdle issues management run
The biggest hurdle in deals like these is the management issues - who will run the company.
action again based beat clearly credit deserves equity higher increased investors itself starting strong taking together
The beat was based on a combination of strong top-line growth, increased equity income, and higher other revenue. Merck deserves credit for starting to take action to put itself back together again and investors are clearly taking up the story.
bad good quarter quiet
It was a good quarter and quiet with no surprises, which is never a bad thing.
bought business chief looking parts review strategic whether
They're looking for a new chief executive. There is a strategic review going on looking at whether all the business should be bought or parts of it.
acting companies company couple facing happen happens ironically run supposed turnaround
The company's not going out of business, but ironically it's acting like a cyclical, which drug companies aren't supposed to do. The turnaround may not happen for a couple of years, but it's a well run company that just happens to be facing a lot of problems.
bristol company concern decent drop far next patent shoe
The concern is that Bristol could be the next shoe to drop as far as patent expiration and reining in the numbers, ... But the company has a pretty decent late-stage pipeline.
bad good negative products
You've got the good with the bad with the sector, ... The good being that you've got good products and fundamentals and the bad being that you've got some negative headlines.
currently estimates global group multiple trades
The global pharmaceutical group multiple on 2006 earnings-per-share estimates is currently about 15 times, and Pfizer currently trades at 10.9 times.
washed
I think that the stock's probably washed out for a while,
help
It's been a long frustrating case, ... We would really like to get some help from the public.